Results 1 to 10 of about 1,010 (146)

The use of intranasal glucocorticosteroids in patients with chronic rhinosinusitis in the preoperative period [PDF]

open access: yesМедицинский совет, 2022
Introduction. Chronic rhinosinusitis is a disease that occurs everywhere, characterized by inflammation of the mucous membrane of the paranasal sinuses and nasal cavity.
I. I. Chernushevich   +4 more
doaj   +4 more sources

Intranasal glucocorticosteroids in acute rhinosinusitis: prescribe or not prescribe?

open access: yesМедицинский совет, 2014
According to the global and Russian medical care standards, intranasal glucocorticosteroids (InGCS) are included in the treatment regimen for acute rhinosinusitis (ARS). The medications are recommended as monotherapy in milder forms of the disease and in
V. V. Shilenkova
doaj   +2 more sources

The use of intranasal glucocorticosteroids in the treatment of persistent allergic rhinitis after COVID-19 infection

open access: yesМедицинский совет, 2022
Introduction. Modern algorithms for the diagnosis and treatment of allergic rhinitis (AR) recommend a stepwise approach for managing symptoms of the disease.
T. Yu. Vladimirova   +2 more
doaj   +2 more sources

How an online survey on the treatment of allergic rhinitis and its impact on asthma (ARIA) detected specialty-specific knowledge-gaps [PDF]

open access: yesWorld Allergy Organization Journal, 2015
Background To enhance the dissemination of the ARIA document (Allergic rhinitis (AR) and its impact on asthma) in Mexico, a Working Group composed of 35 specialists of 8 professional medical societies developed a transculturized ARIA México 2014 ...
Désirée ES Larenas Linnemann   +2 more
doaj   +2 more sources

NEW WAYS OF TREATING PERENNIAL ALLERGIC RHINITIS [PDF]

open access: yesНаука и инновации в медицине, 2018
Moscow State University of Medicine and Dentistry n.a. A.I. Evdokimov Selecting the proper treatment of perennial allergic rhinitis (PAR) today is often unsuccessful.
N P Dzhimsheleishvili   +2 more
doaj   +2 more sources

Intranasal glucocorticosteroids for the complex treatment of patients with chronic diseases of the nose and paranasal sinuses

open access: yesМедицинский совет, 2020
Intriduction. Chronic rhinitis and rhinosinusitis noticeably deteriorate the patients’ quality of life and lead to the accompanying upper airway pathology development.
P. A. Kochetkov   +2 more
doaj   +3 more sources

Quantitative expression of osteopontin in nasal mucosa of patients with allergic rhinitis: effects of pollen exposure and nasal glucocorticoid treatment [PDF]

open access: yesAllergy, Asthma & Clinical Immunology, 2010
Background Osteopontin (OPN) is a multifunctional cytokine that has been primarily investigated in Th1 diseases. Recently, it has also been implicated in Th2-mediated allergic diseases, such as asthma.
O'Neil Serena E   +5 more
doaj   +3 more sources

Allergic rhinitis – a review of current diagnostic and therapeutic methods [PDF]

open access: yesQuality in Sport
Allergic rhinitis (AR) is a common disease characterized by inflammation of the nasal mucosa caused by exposure to allergens such as pollen, house dust mites, animal dander, and molds. Symptoms include sneezing, nasal itching, watery discharge, and nasal
Kacper Kwiliński   +6 more
doaj   +3 more sources

Acupuncture in addition to budesonide does not further improve RQLQ apart from the sleep domain [PDF]

open access: yesRhinology Online, 2020
Background: Acupuncture can effectively alleviate the nasal symptoms of allergic rhinitis (AR); however, the mechanism is unclear. Previous studies suggested it may be related to improve hypothalamus-pituitary-adrenal (HPA) axis dysfunction.
Shan-ze Wang   +7 more
doaj   +1 more source

Intranasal corticosteroid use in patients with allergic rhinitis

open access: yesConsilium Medicum, 2021
Allergic rhinitis (AR) is one of the most common diseases in the world, which is based on IgE-mediated inflammation that develops after exposure to various allergens.
Svetlana V. Starostina   +1 more
doaj   +1 more source

Home - About - Disclaimer - Privacy